A 3,239-patient combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) analysis of the effect of CR vs. responses < CR on long-term survival in newly-diagnosed AML treated with ara-C-containing regimens:: Implications for targeted drug development

被引：4

作者：

Estey, Elihu ^{[1
]}

Sun, Zhuoxin ^{[2
]}

Rowe, Jacob ^{[2
]}

Faderl, Stefan ^{[1
]}

Cassileth, Peter ^{[2
]}

Sartiano, George ^{[2
]}

Tartaglia, Anthony ^{[2
]}

Garcia-Manero, Guillermo ^{[1
]}

Cripe, Larry ^{[2
]}

Bennett, John ^{[2
]}

Kantarjian, Hagop ^{[1
]}

Tallman, Martin ^{[2
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

[2] Eastern Cooperat Oncol Grp, Brookline, MA USA

来源：

关键词：

D O I：

10.1182/blood.V110.11.298.298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

298

引用

页码：94A / 94A

页数：1

A 3,239-patient combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) analysis of the effect of CR vs. responses &lt; CR on long-term survival in newly-diagnosed AML treated with ara-C-containing regimens:: Implications for targeted drug development